# Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune Diseases

> **NCT07388212** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 27 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** CD19/BCMA in vivo CAR-T

## Key facts

- **NCT ID:** NCT07388212
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-23
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07388212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07388212, "Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune Diseases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07388212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*